LGND-1-18-19

LGND – time to buy a strong free cash flow generator Ligand’s business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company’s revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material. It’s Read more…

Login